Asalyxa is focused on treating significant unmet medical needs through development of a microparticle-based immune cell targeting therapy.
THE PANTHER PLATFORM
PANTHER reimagines the treatment of human disease. With safety in mind at the onset, the biodegradable poly-aspirin backbone of PANTHER breaks down into salicylic acid (a well-known and safe anti-inflammatory agent) and adipic acid (a food additive classified as GRAS by the FDA).
